Superior mesenteric artery vasoactivity in hyperlipidemic watanabe rabbits versus normal lipidemic New zealand controls

Kathie M. Dalessandri, Bo M T Lantz, Hidekazu Tsukamoto, Daniel P Link, John Brock

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recent in vitro studies on isolated coronary and mesenteric arteries have shown that hyperlipidemia appears to hypersensitize the vascular arterial smooth muscle to drugs such as ergonovine and that this increased contractility seems to be mediated by a serotinergic mechanism. This results in vasospasm with exposure to certain vasoactive drugs such as serotonin or norepinephrine. However, in vivo quantification of this observed phenomenon has not been done. In the present study we used Watanabe hereditary hyperlipidemic (WHHL) rabbits (cholesterol level 459 ± 216 mg/dL) and the normal lipidemic New Zealand white (NZW) rabbit (cholesterol level 35 ± 19) as a control in the study of hyperlipidemia and blood flow changes in response to various vasoactive drugs. Blood flow measurements were made by the video dilution technique (VDT) following catheterization of the superior mesenteric artery. The serotinergic vasoactive drug ergonovine maleate was injected into the superior mesenteric artery at low dose (0.002 mg/kg) and high dose (0.004 mg/kg). A significant decrease (p < 05) in blood flow was observed in response to high-dose ergonovine maleate in WHHL rabbits compared to the NZW rabbits. This in vivo experiment confirms the in vitro studies showing that hyperlipidemia sensitizes mesenteric arteries in the presence of serotinergic stimuli. The vasodilators verapamil hydrochloride and calcitonin gene-related peptide (CGRP) injected into the superior mesenteric artery caused a marked increase in flow in both the WHHL and the normal lipidemic NZW rabbits. This model can be used in the assessment of superior mesenteric artery ischemia and its reversal.

Original languageEnglish (US)
Pages (from-to)471-477
Number of pages7
JournalJournal of Investigative Surgery
Volume2
Issue number4
DOIs
StatePublished - 1989

Fingerprint

Superior Mesenteric Artery
New Zealand
Ergonovine
Rabbits
Hyperlipidemias
Mesenteric Arteries
Pharmaceutical Preparations
Cholesterol
Indicator Dilution Techniques
Calcitonin Gene-Related Peptide
Verapamil
Vasodilator Agents
Vascular Smooth Muscle
Catheterization
Serotonin
Coronary Vessels
Norepinephrine

Keywords

  • Blood flow
  • CGRP
  • Ergonovine
  • Superior mesenteric artery
  • Vasoactivity
  • Verapamil
  • Video dilution technique
  • Watanabe hereditary hyperlipidemic rabbits

ASJC Scopus subject areas

  • Surgery

Cite this

Superior mesenteric artery vasoactivity in hyperlipidemic watanabe rabbits versus normal lipidemic New zealand controls. / Dalessandri, Kathie M.; Lantz, Bo M T; Tsukamoto, Hidekazu; Link, Daniel P; Brock, John.

In: Journal of Investigative Surgery, Vol. 2, No. 4, 1989, p. 471-477.

Research output: Contribution to journalArticle

Dalessandri, Kathie M. ; Lantz, Bo M T ; Tsukamoto, Hidekazu ; Link, Daniel P ; Brock, John. / Superior mesenteric artery vasoactivity in hyperlipidemic watanabe rabbits versus normal lipidemic New zealand controls. In: Journal of Investigative Surgery. 1989 ; Vol. 2, No. 4. pp. 471-477.
@article{957136b85bf0493289c75fb364cd1b24,
title = "Superior mesenteric artery vasoactivity in hyperlipidemic watanabe rabbits versus normal lipidemic New zealand controls",
abstract = "Recent in vitro studies on isolated coronary and mesenteric arteries have shown that hyperlipidemia appears to hypersensitize the vascular arterial smooth muscle to drugs such as ergonovine and that this increased contractility seems to be mediated by a serotinergic mechanism. This results in vasospasm with exposure to certain vasoactive drugs such as serotonin or norepinephrine. However, in vivo quantification of this observed phenomenon has not been done. In the present study we used Watanabe hereditary hyperlipidemic (WHHL) rabbits (cholesterol level 459 ± 216 mg/dL) and the normal lipidemic New Zealand white (NZW) rabbit (cholesterol level 35 ± 19) as a control in the study of hyperlipidemia and blood flow changes in response to various vasoactive drugs. Blood flow measurements were made by the video dilution technique (VDT) following catheterization of the superior mesenteric artery. The serotinergic vasoactive drug ergonovine maleate was injected into the superior mesenteric artery at low dose (0.002 mg/kg) and high dose (0.004 mg/kg). A significant decrease (p < 05) in blood flow was observed in response to high-dose ergonovine maleate in WHHL rabbits compared to the NZW rabbits. This in vivo experiment confirms the in vitro studies showing that hyperlipidemia sensitizes mesenteric arteries in the presence of serotinergic stimuli. The vasodilators verapamil hydrochloride and calcitonin gene-related peptide (CGRP) injected into the superior mesenteric artery caused a marked increase in flow in both the WHHL and the normal lipidemic NZW rabbits. This model can be used in the assessment of superior mesenteric artery ischemia and its reversal.",
keywords = "Blood flow, CGRP, Ergonovine, Superior mesenteric artery, Vasoactivity, Verapamil, Video dilution technique, Watanabe hereditary hyperlipidemic rabbits",
author = "Dalessandri, {Kathie M.} and Lantz, {Bo M T} and Hidekazu Tsukamoto and Link, {Daniel P} and John Brock",
year = "1989",
doi = "10.3109/08941938909018272",
language = "English (US)",
volume = "2",
pages = "471--477",
journal = "Journal of Investigative Surgery",
issn = "0894-1939",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Superior mesenteric artery vasoactivity in hyperlipidemic watanabe rabbits versus normal lipidemic New zealand controls

AU - Dalessandri, Kathie M.

AU - Lantz, Bo M T

AU - Tsukamoto, Hidekazu

AU - Link, Daniel P

AU - Brock, John

PY - 1989

Y1 - 1989

N2 - Recent in vitro studies on isolated coronary and mesenteric arteries have shown that hyperlipidemia appears to hypersensitize the vascular arterial smooth muscle to drugs such as ergonovine and that this increased contractility seems to be mediated by a serotinergic mechanism. This results in vasospasm with exposure to certain vasoactive drugs such as serotonin or norepinephrine. However, in vivo quantification of this observed phenomenon has not been done. In the present study we used Watanabe hereditary hyperlipidemic (WHHL) rabbits (cholesterol level 459 ± 216 mg/dL) and the normal lipidemic New Zealand white (NZW) rabbit (cholesterol level 35 ± 19) as a control in the study of hyperlipidemia and blood flow changes in response to various vasoactive drugs. Blood flow measurements were made by the video dilution technique (VDT) following catheterization of the superior mesenteric artery. The serotinergic vasoactive drug ergonovine maleate was injected into the superior mesenteric artery at low dose (0.002 mg/kg) and high dose (0.004 mg/kg). A significant decrease (p < 05) in blood flow was observed in response to high-dose ergonovine maleate in WHHL rabbits compared to the NZW rabbits. This in vivo experiment confirms the in vitro studies showing that hyperlipidemia sensitizes mesenteric arteries in the presence of serotinergic stimuli. The vasodilators verapamil hydrochloride and calcitonin gene-related peptide (CGRP) injected into the superior mesenteric artery caused a marked increase in flow in both the WHHL and the normal lipidemic NZW rabbits. This model can be used in the assessment of superior mesenteric artery ischemia and its reversal.

AB - Recent in vitro studies on isolated coronary and mesenteric arteries have shown that hyperlipidemia appears to hypersensitize the vascular arterial smooth muscle to drugs such as ergonovine and that this increased contractility seems to be mediated by a serotinergic mechanism. This results in vasospasm with exposure to certain vasoactive drugs such as serotonin or norepinephrine. However, in vivo quantification of this observed phenomenon has not been done. In the present study we used Watanabe hereditary hyperlipidemic (WHHL) rabbits (cholesterol level 459 ± 216 mg/dL) and the normal lipidemic New Zealand white (NZW) rabbit (cholesterol level 35 ± 19) as a control in the study of hyperlipidemia and blood flow changes in response to various vasoactive drugs. Blood flow measurements were made by the video dilution technique (VDT) following catheterization of the superior mesenteric artery. The serotinergic vasoactive drug ergonovine maleate was injected into the superior mesenteric artery at low dose (0.002 mg/kg) and high dose (0.004 mg/kg). A significant decrease (p < 05) in blood flow was observed in response to high-dose ergonovine maleate in WHHL rabbits compared to the NZW rabbits. This in vivo experiment confirms the in vitro studies showing that hyperlipidemia sensitizes mesenteric arteries in the presence of serotinergic stimuli. The vasodilators verapamil hydrochloride and calcitonin gene-related peptide (CGRP) injected into the superior mesenteric artery caused a marked increase in flow in both the WHHL and the normal lipidemic NZW rabbits. This model can be used in the assessment of superior mesenteric artery ischemia and its reversal.

KW - Blood flow

KW - CGRP

KW - Ergonovine

KW - Superior mesenteric artery

KW - Vasoactivity

KW - Verapamil

KW - Video dilution technique

KW - Watanabe hereditary hyperlipidemic rabbits

UR - http://www.scopus.com/inward/record.url?scp=0024856740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024856740&partnerID=8YFLogxK

U2 - 10.3109/08941938909018272

DO - 10.3109/08941938909018272

M3 - Article

VL - 2

SP - 471

EP - 477

JO - Journal of Investigative Surgery

JF - Journal of Investigative Surgery

SN - 0894-1939

IS - 4

ER -